TONY TURAN: Open Payments
NPI 1285120675 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,235 in 55 payments from 12 companies in 2025. Trend: 2023 $809 · 2024 $1,753 · 2025 $1,235
Food & beverage: $1,235
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $231 |
| Merck Sharp & Dohme LLC | 8 | $170 |
| E.R. Squibb & Sons, L.L.C. | 9 | $158 |
| Amgen Inc. | 4 | $123 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $94 |
| Novartis Pharmaceuticals Corporation | 4 | $88 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $78 |
| Novo Nordisk Inc | 4 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $71 |
| CVRx, Inc. | 4 | $69 |
Products named: VERQUVO, REPATHA, BREZTRI, CAMZYOS, ELIQUIS, LOKELMA, Kerendia, LEQVIO.
Industry payments across MS — which companies pay providers there.
